USD
( +0.00%
At Close (As of Jan 1, 1970)
$5.37B
Market Cap
28.32
P/E Ratio
4.29
EPS
$239.07
52 Week High
$108.60
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $1.7B |
Total Revenue | $3B |
Cost Of Revenue | $1.3B |
Costof Goods And Services Sold | $1.3B |
Operating Income | $151M |
Selling General And Administrative | $995M |
Research And Development | $162M |
Operating Expenses | $1.6B |
Investment Income Net | - |
Net Interest Income | -$76M |
Interest Income | $8M |
Interest Expense | $84M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $275M |
Income Before Tax | $75M |
Income Tax Expense | $5.3M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $70M |
Comprehensive Income Net Of Tax | - |
Ebit | $178M |
Ebitda | $453M |
Net Income | $70M |
Field | Value (USD) |
---|---|
Total Assets | $7.1B |
Total Current Assets | $1.5B |
Cash And Cash Equivalents At Carrying Value | $290M |
Cash And Short Term Investments | $290M |
Inventory | $600M |
Current Net Receivables | $459M |
Total Non Current Assets | $5.6B |
Property Plant Equipment | $612M |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2.3B |
Intangible Assets Excluding Goodwill | $2.3B |
Goodwill | $2.6B |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $121M |
Other Non Current Assets | - |
Total Liabilities | $2.8B |
Total Current Liabilities | $649M |
Current Accounts Payable | $141M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $100M |
Total Non Current Liabilities | $2.2B |
Capital Lease Obligations | $99M |
Long Term Debt | $1.6B |
Current Long Term Debt | $100M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.8B |
Other Current Liabilities | $367M |
Other Non Current Liabilities | $104M |
Total Shareholder Equity | $4.3B |
Treasury Stock | - |
Retained Earnings | $4.1B |
Common Stock | $48M |
Common Stock Shares Outstanding | $47M |
Field | Value (USD) |
---|---|
Operating Cashflow | $636M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $275M |
Capital Expenditures | $126M |
Change In Receivables | - |
Change In Inventory | $1.7M |
Profit Loss | - |
Cashflow From Investment | -$99M |
Cashflow From Financing | -$422M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $64M |
Dividend Payout Common Stock | $64M |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$200M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $70M |
Field | Value (USD) |
---|---|
Gross Profit | $1.7B |
Total Revenue | $3B |
Cost Of Revenue | $1.3B |
Costof Goods And Services Sold | $1.3B |
Operating Income | $151M |
Selling General And Administrative | $995M |
Research And Development | $162M |
Operating Expenses | $1.6B |
Investment Income Net | - |
Net Interest Income | -$76M |
Interest Income | $8M |
Interest Expense | $84M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $275M |
Income Before Tax | $75M |
Income Tax Expense | $5.3M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $70M |
Comprehensive Income Net Of Tax | - |
Ebit | $178M |
Ebitda | $453M |
Net Income | $70M |
Field | Value |
---|---|
Ex Dividend Date | 2025-08-15 |
Declaration Date | 2025-07-31 |
Record Date | 2025-08-15 |
Payment Date | 2025-09-15 |
Amount | 0.34 |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Teleflex Incorporated (TFX), based in Wayne, Pennsylvania, is a leading global provider of innovative medical devices that cater to the critical care and surgical markets. With a focus on advancing and enhancing patient care, Teleflex develops a diverse portfolio of specialty products designed to improve safety and efficacy across various medical procedures. The company's commitment to innovation and quality has positioned it as a trusted partner in healthcare, serving clinicians and patients worldwide.